A tablet that features a combination of midazolam and ketamine, MELT-300 leverages Catalent’s ‘Zydis’ technology for sublingual delivery, dissolving in seconds for rapid absorption.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback